{"id":"W2469735602","doi":"10.1080/14740338.2016.1207760","title":"A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Homoharringtonine; Myeloid leukemia; Adverse effect; Pharmacology; Tyrosine-kinase inhibitor; Oncology; Internal medicine; Intensive care medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001541,0.0009857375,0.003354246,0.0003152745,0.0001889212,0.000008448289,0.0004125779,0.000442491,0.0008681618],"category_scores_gemma":[0.0002776004,0.000503201,0.001829854,0.0003739726,0.0002064597,0.00007094824,0.00006359416,0.000221197,0.00007821384],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02201766,"about_ca_system_score_gemma":0.006756689,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001520199,"about_ca_topic_score_gemma":0.00002207398,"domain_scores_codex":[0.9945583,0.0005909859,0.002003907,0.0009392643,0.001331559,0.0005759516],"domain_scores_gemma":[0.9936979,0.002117418,0.001517229,0.001961194,0.0005262932,0.0001799441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007829724,0.0006131878,8.737046e-7,0.003298968,0.001964621,0.000001733991,0.0004328738,0.00002919493,0.000009685721,0.0002791298,0.002039925,0.9905468],"study_design_scores_gemma":[0.01564882,0.00200382,0.0000323952,0.02281252,0.001289668,0.00003895413,0.00004415938,0.0006635541,0.0003647509,0.0000172767,0.9567021,0.0003819524],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008739287,0.9857046,0.0002040073,0.0006742529,0.001524597,0.009722006,0.0007328063,0.00005771891,0.001371263],"genre_scores_gemma":[0.0001550395,0.9930672,0.0001905852,0.00003409871,0.00139981,0.002124527,0.001144213,0.0001588794,0.001725665],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9901649,"threshold_uncertainty_score":0.999742,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07044490029049531,"score_gpt":0.3938654674538767,"score_spread":0.3234205671633814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}